**Author details**

*Aortic Stenosis - Current Perspectives*

Symptomatic coronary obstruction following TAVR is rare but a lifethreatening complication. Multicentre registry data shows an incidence of 0.6%. It was observed more frequently with balloon expandable valve and in those with a previous surgical prosthesis [24]. Low lying coronary ostium and shallow sinus of Valsalva were anatomical factors associated with the risk for coronary

The incidence of complications with TEE is <1%. Dental trauma, oral bleeding,

Respiratory dependence, hypotension, nausea and vomiting are among common, complete description of anaesthesia related complications is beyond the scope

TAVR, a novel approach started as an impossible idea, witnessed a remarkable journey and now is an established therapy in management of symptomatic severe Aortic stenosis patients. Outcomes post TAVR are bound to get better as technology improves and expertise increases. "TAVR first approach may be the

STS PROM society of thoracic surgeons, predicted risk of mortality

V tach/V fib ventricular tachycardia/ventricular fibrillation

PPI permanent pacemaker implantation

VARC valve academic research consortium

*5.6.4 Trans oesophageal echo (TEE) related complications*

oesophageal erosions and rarely oesophageal rupture.

CARE Hospitals, Banjara Hills, Hyderabad.

There are no conflicts of interest.

MI myocardial infarction

CT surgeon cardiothoracic surgeon

CPS cerebral protection system LAA left atrial appendage

PVL paravalvular leak

AS aortic stenosis

*5.6.5 Anaesthesia-related complications*

*5.6.3 Coronary obstruction*

obstruction [24].

of this chapter.

**6. Conclusion**

**Acknowledgements**

**Conflict of interest**

**Appendix**

future."

**60**

Naresh Kumar Monigari\* and Anoop Agarwal CARE Hospitals, Hyderabad, India

\*Address all correspondence to: medico.ktya@gmail.com

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
